1)Keelan JA, et al : Cytokines, prostaglandins and parturition--a review. Placenta 24(Suppl A) : S33-S46, 2003
2)Goldenberg RL, et al : Intrauterine infection and preterm delivery. N Engl J Med 342 : 1500-1507, 2000
3)Taylor-Robinson D, et al : Genital mycoplasma infections. Wien Klin Wochenschr 109 : 578-583, 1997
4)McGregor JA, et al : Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase : results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 170 : 1048-1059 ; discussion 1059-1060, 1994
5)Cox SM, et al : Assay of bacterial endotoxin(lipopolysaccharide) in human amniotic fluid : potential usefulness in diagnosis and management of preterm labor. Am J Obstet Gynecol 159 : 99-106, 1988
6)Andrews WW, et al : Amniotic fluid interleukin-6 : correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 173 : 606-612, 1995
7)母子衛生研究会 : 母子保健の主なる統計.母子衛生研究会,2020
8)Lockwood CJ : Predicting premature delivery--no easy task. N Engl J Med 346 : 282-284, 2002
9)Hillier SL, et al : Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333 : 1737-1742, 1995
10)早産リスク因子の解明と具体的な予防法確立に関する小委員会 : 周産期委員会報告.日産婦会誌62 : 1520, 2010
11)Shimano S, et al : Analysis of the prevalence of bacterial vaginosis and Chlamydia trachomatis infection in 6083 pregnant women at a hospital in Otaru, Japan. J Obstet Gynaecol Res 30 : 230-236, 2004
12)日本産科婦人科学会,他(編・監修) : 産婦人科診療ガイドライン―産科編2020,日本産科婦人科学会,2020
13)McDonald HM, et al : Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (1) : CD000262, 2007
14)Brocklehurst P, et al : Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (1) : CD000262, 2013
15)齋藤 滋,他 : 早産のリスク因子の解明と具体的な予防法確立に関する小委員会.日産婦会誌63 : 1327-1329, 2011
16)島野敏司 : 【周産期医療とinflammatory response】細菌性腟症.周産期医39 : 681-690, 2009
17)Taylor-Robinson D : The future of bacterial vaginosis-related research. Int J Gynaecol Obstet 67(Suppl 1) : S35-S38, 1999
18)Amsel R, et al : Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 : 14-22, 1983
19)Nugent RP, et al : Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 : 297-301, 1991
20)Verstraelen H, et al : Modified classification of Gram-stained vaginal smears to predict spontaneous preterm birth : a prospective cohort study. Am J Obstet Gynecol 196 : 528.e1-528.e6, 2007
21)Workowski KA, et al;Centers for Disease Control and Prevention : Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64 : 1-137, 2015
22)Yudin MH, et al : Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy : a randomized trial. Obstet Gynecol 102 : 527-534, 2003
23)Sangkomkamhang US, et al : Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2015 : CD006178, 2015
24)Mastromarino P, et al : Bacterial vaginosis : a review on clinical trials with probiotics. New Microbiol 36 : 229-238, 2013
25)Arai EN, et al : Probiotics including Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis may prevent recurrent spontaneous preterm delivery. J Obstet Gynaecol Res 48 : 688-693, 2022
26)Otsuki K, et al : Review, role of lactoferrin in preventing preterm delivery. Biometals, 2022(in press)
27)Jang YS, et al : Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-beta signaling. Mucosal Immunol 8 : 906-917, 2015
28)Kim WS, et al : Inhibitory effects of synthetic peptides containing bovine lactoferrin C-lobe sequence on bacterial growth. Korean J Food Sci Anim Resour 36 : 452-457, 2016
29)Rahman M, et al : Bovine lactoferrin region responsible for binding to bifidobacterial cell surface proteins. Biotechnol Lett 31 : 863-868, 2009
30)Cotch MF, et al : Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24 : 353-360, 1997
31)Yoon BH, et al : The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 189 : 919-924, 2003
32)Yoneda N, et al : Polymicrobial amniotic fluid infection with Mycoplasma/Ureaplasma and other bacteria induces severe intra-amniotic inflammation associated with poor perinatal prognosis in preterm labor. Am J Reprod Immunol 75 : 112-125, 2016
33)Elliott B, et al : Maternal gonococcal infection as a preventable risk factor for low birth weight. J Infect Dis 161 : 531-536, 1990
34)Vile Y, et al : Chlamydia trachomatis infection in prelabour amniorrhexis. Br J Obstet Gynaecol 104 : 1091-1093, 1997
35)Andrews WW, et al : The preterm prediction study : association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 183 : 662-668, 2000
36)Moreno I, et al : Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 215 : 684-703, 2016